| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 05/13/2008 | US7371938 Soybean variety 4008211 |
| 05/13/2008 | US7371936 Soybean variety XB005A06 |
| 05/13/2008 | US7371935 Transgenic plants and methods for production thereof |
| 05/13/2008 | US7371934 Lettuce cultivar ‘blade’ |
| 05/13/2008 | US7371933 Lettuce cultivar 80-0601013-B |
| 05/13/2008 | US7371932 Lettuce cultivar 50-0401002-B |
| 05/13/2008 | US7371931 Lettuce cultivar 50-0301005-B |
| 05/13/2008 | US7371930 Lettuce cultivar 21-0406127-B |
| 05/13/2008 | US7371929 Lettuce cultivar 50-0301007-B |
| 05/13/2008 | US7371928 Plant seed-specific expression promoter derived from sesame and seed-specific expression vector comprising the promoter |
| 05/13/2008 | US7371927 Methods for modulating plant growth and biomass |
| 05/13/2008 | US7371926 DNA of given sequence encoding signal peptide which targets fusion polypeptide produced to chloroplasts; plastid or apoplast; production of ethanol |
| 05/13/2008 | US7371925 Cytokinin oxidase promoter from maize |
| 05/13/2008 | US7371924 for decreasing saturated fatty acid levels as a component of total triglycerides found in plant oils; genetic engineering |
| 05/13/2008 | US7371923 Process of generating transplastomic plants or plant cells devoid of a selection marker |
| 05/13/2008 | US7371922 Nuclear transfer with porcine embryonic stem cells |
| 05/13/2008 | US7371921 Nonhuman animal model non-responsive to mycoplasma-origin lipoprotein/lipopeptide |
| 05/13/2008 | US7371920 To facilitate the characterization of the pathogenic mechanisms of Alzheimer's disease and development of diagnostics, therapies and therapeutic compounds |
| 05/13/2008 | US7371860 PNA monomer and precursor |
| 05/13/2008 | US7371859 Peptide nucleic acid monomers; 1-(4-(benzothiazolyl-, benzoxazolyl-, benzofuranyl-, and benzothiophenyl- sulfonyl)piperidin-3-one-1-ylcarbonylmethyl)adenines; suitable for automatic and parallel synthesis; increased yields |
| 05/13/2008 | US7371851 Hybridizing and ligating double stranded nucleic acids; identifying binary codes using labeled probes; does not require use of restriction enzymes |
| 05/13/2008 | US7371850 Method and composition for reducing expression of ROCK-II |
| 05/13/2008 | US7371848 Chimeric promoters comprising a caulimovirus promoter enhancer for use in plants |
| 05/13/2008 | US7371847 Yeast-origin promoter and vector and expression system using the same |
| 05/13/2008 | US7371846 Chemokine coreceptor fusion for use prevention and treatment of viral infection; immunotherapy |
| 05/13/2008 | US7371845 MAGE-A3 peptides presented by HLA class II molecules |
| 05/13/2008 | US7371844 Polypeptide of given sequence which binds to receptors; gene expression; use in treatment of osteoporosis, bone loss and raising cyclic AMP levels in cells |
| 05/13/2008 | US7371843 Cultured Xenopus laevis cell lines expressing mutant Adenomatous polyposis coli gene |
| 05/13/2008 | US7371842 Polynucleotide encoding a 35 KDA protein thats binds to WF00144 |
| 05/13/2008 | US7371841 Identifying modulator of cold sensation and pain; drug screening; cancer diagnosis |
| 05/13/2008 | US7371839 having high specific activity and strong oxidant resistance, and having excellent detergency that is to be added to a detergent |
| 05/13/2008 | US7371838 expression cassette encoding a beta 1,4-N-acetylglucosaminyl (GalNAc) transferase polypeptide; campylobacter jejuni (C. jejuni); host cells; enzyme involved in synthesis of lipooligosaccharides including gangliosides and ganglioside mimics |
| 05/13/2008 | US7371837 Human virus causing respiratory tract infection and uses thereof |
| 05/13/2008 | US7371836 PRO526 nucleic acids |
| 05/13/2008 | US7371835 p53-dependent apoptosis-inducing protein and method of screening for apoptosis regulator |
| 05/13/2008 | US7371833 Nucleic acid molecules with specific recognition of native PrPSc, production and use |
| 05/13/2008 | US7371832 Polynucleotides encoding molecules associated with cell proliferation |
| 05/13/2008 | US7371828 Extracellular signal-regulated kinase sequences and methods of production and use |
| 05/13/2008 | US7371827 Antibodies against the PRO1126 polypeptide |
| 05/13/2008 | US7371826 Comprising human immunoglobulin g1 fc region, which mediates antibody-dependent cell-mediated cytotoxicity in presence of effector cells more effectively; binds fc gamma receptor iii with better affinity |
| 05/13/2008 | US7371824 PRO6093 polypeptides |
| 05/13/2008 | US7371823 Cyclic nucleotide-gated cation channel subunit 3B (CNG3B) polypeptides |
| 05/13/2008 | US7371822 Polypeptide of given sequence; use in prevention and treatment of cardiovascular, metabolic, inflammatory disorders; |
| 05/13/2008 | US7371821 Polypeptide of given sequence used as immunogen; cytokine adjuvant; |
| 05/13/2008 | US7371819 Differs from nucleotide sequence of wild-type IFN alpha -17 gene, in that it comprises one or several SNPs (Single Nucleotide Polymorphism[s]); anticarcinogenic and antiproliferative agents; side effect reduction |
| 05/13/2008 | US7371815 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative and tumor disorders |
| 05/13/2008 | US7371812 Antiangiogenic peptides |
| 05/13/2008 | US7371811 Polypeptide of given sequence; diagnosis and treatment of bipolar disorders |
| 05/13/2008 | US7371810 Tachykinin peptides, precursor peptides thereof and genes encoding the same |
| 05/13/2008 | US7371735 Inhibitor oligonucleotides and their use for specific repression of a gene |
| 05/13/2008 | US7371734 Oligonucleotide compositions and their use for the modulation of immune responses |
| 05/13/2008 | US7371723 Therapeutic agents comprising pro-apoptotic proteins |
| 05/13/2008 | US7371585 Membranes incorporating recognition moieties |
| 05/13/2008 | US7371577 FLP-mediated gene modification in mammalian cells, and compositions and cells useful therefor |
| 05/13/2008 | US7371574 Antibody antagonists of VE-cadherin without adverse effects on vascular permeability |
| 05/13/2008 | US7371573 Propagation and/or derivation of embryonic stem cells |
| 05/13/2008 | US7371571 Recombinant mycobacteria overexpressing D-alanine ligase gene and uses therefore |
| 05/13/2008 | US7371570 replication-competent; comprising an epstein-barr virus (EBV)-specific transcriptional regulatory element (TRE); genetic engineering |
| 05/13/2008 | US7371569 Methods for preparing human thrombopoietin polypeptides by mammalian cell cultures |
| 05/13/2008 | US7371568 Centromere, telomere and recognition sequences for recombinase; fragment comprising antibody gene; site-directed recombination detected by green fluorescent protein |
| 05/13/2008 | US7371559 Polynucleotide of given sequence; treatment of chronic pain, migraine, asthma, urge incontinence, psoriasis, and cancer |
| 05/13/2008 | US7371558 Genetically modified eschrichia strain which is capable of biocoversion a single cacrbon source into 1, 3 propanediol using fermentation; bioreactors |
| 05/13/2008 | US7371555 Polypeptides having α-H-α-amino acid amide racemase activity and nucleic acids encoding the same |
| 05/13/2008 | US7371554 Lachrymatory-factor synthase for use in identifying medicants for dry eye; producing onions with reduced lachrymatory factor and eye stinging |
| 05/13/2008 | US7371553 Chemically modified enzymes with multiple charged variants |
| 05/13/2008 | US7371552 Polypeptide |
| 05/13/2008 | US7371551 Feedback-resistant homoserine transsuccinylases |
| 05/13/2008 | US7371548 Expression vector comprising nucleotide sequences coding enzymatic polypeptide associated with polyketide biosynthesis for use in identifying modulators of immune response and cell proliferative disorders and which prevent propagation of insects, fungi and parasites |
| 05/13/2008 | US7371546 Heat stable and saccharide specific hydrolase for use in producing glucose from starch |
| 05/13/2008 | US7371543 Factor VII or VIIa-like molecules |
| 05/13/2008 | US7371542 Expression vector comprising scaffold/matrix attached region (S/MAR), an origin of replication (ORI) and one replication initiation factor for use as tool in transfer and expression of heterologous nucleotide sequences; biodrugs |
| 05/13/2008 | US7371541 Screening for substances capable of regulating signal transduction from dopamine or adenosine receptor to adenylate cyclase; measuring effector activity or index value; Gm1 |
| 05/13/2008 | US7371540 Encodes a protein that interacts with human CD33, the DNA being highly homologous to a portion of the human dystrophin gene. screening for leukemic cells and associated disease states; gene therapy |
| 05/13/2008 | US7371539 Targeted polypeptide degradation |
| 05/13/2008 | US7371535 Detect binding with cells transfected with DNA |
| 05/13/2008 | US7371531 Detection without amplification and interference; measuring efficacy; packaged array can be used in robotic assembly for automated analysis |
| 05/13/2008 | US7371529 Methods and compositions for modulating gluconeogenesis using PGC-1 |
| 05/13/2008 | US7371521 Using physical map of pig genome to identify mutants in mast/stem cell growth factor receptor (KIT) for use in determining coat color in swine |
| 05/13/2008 | US7371520 Methods and apparati using single polymer analysis |
| 05/13/2008 | US7371517 High purity X-chromosome bearing and Y-chromosome bearing populations of spermatozoa |
| 05/13/2008 | US7371515 Detection of cancer genes in sample; obtain cells, transform with vector, detect cell in which tumor development has been induced, detect gene associated with cancer |
| 05/13/2008 | US7371423 For improving rheological properties of a flour dough and the quality of bread, alimentary paste products, noodles and cakes |
| 05/13/2008 | US7371404 Amphoteric liposomes and their use |
| 05/13/2008 | US7371391 Papilloma virus capsomere vaccine formulations and methods of use |
| 05/13/2008 | US7371386 Conserved motif of hepatitis C virus E2/NS1 region |
| 05/13/2008 | US7371383 Genetic enginieered mixtures of complementary determining regions(CDR) antigens used for analyzing neutralizing epitopes and for prophylaxis of allergies and respiratory system disorders |
| 05/13/2008 | US7371382 Grafting antibodies to nucleic acids; anticancer agents, osteoporosis, vision defects, antiinflammatory agents, skin disorders |
| 05/13/2008 | US7371380 Anti-Cark antibodies and uses therefor |
| 05/13/2008 | US7371377 Bone morpogenic proteins; endothelial growth factor e (vegfe); wound healing agents; tissue engineering; bradycardial agents |
| 05/13/2008 | US7371375 Protein |
| 05/13/2008 | US7371374 Neural transplantation using pluripotent neuroepithelial cells |
| 05/13/2008 | US7371371 Interleukin-2 mutants with reduced toxicity |
| 05/13/2008 | US7371370 Using colony stimulating factor comprising amino acid sequence variation as therapeutic tools in treatment and prevention of hematopoietic, neurological or reproduction disorders |
| 05/13/2008 | US7371366 GlcNAc phosphotransferase of the lysosomal targeting pathway |
| 05/13/2008 | US7371207 Estrogen receptor α regulated gene expression, related assays and therapeutics |
| 05/13/2008 | CA2437814C Human monoclonal antibodies to fc alpha receptor (cd89) |
| 05/13/2008 | CA2400772C Zinc finger domains and methods of identifying same |
| 05/13/2008 | CA2370535C Replica amplification of nucleic acid arrays |
| 05/13/2008 | CA2360833C Reovirus for the treatment of cellular proliferative disorders |
| 05/13/2008 | CA2336261C Cyclin e2 genes and proteins |